BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38152968)

  • 1. Proteogenomic Data Integration Reveals CXCL10 as a Potentially Downstream Causal Mediator for IL-6 Signaling on Atherosclerosis.
    Prapiadou S; Živković L; Thorand B; George MJ; van der Laan SW; Malik R; Herder C; Koenig W; Ueland T; Kleveland O; Aukrust P; Gullestad L; Bernhagen J; Pasterkamp G; Peters A; Hingorani AD; Rosand J; Dichgans M; Anderson CD; Georgakis MK
    Circulation; 2024 Feb; 149(9):669-683. PubMed ID: 38152968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteogenomic integration reveals CXCL10 as a potentially downstream causal mediator for IL-6 signaling on atherosclerosis.
    Prapiadou S; Živković L; Thorand B; George MJ; van der Laan SW; Malik R; Herder C; Koenig W; Ueland T; Kleveland O; Aukrust P; Gullestad L; Bernhagen J; Pasterkamp G; Peters A; Hingorani AD; Rosand J; Dichgans M; Anderson CD; Georgakis MK
    medRxiv; 2023 Mar; ():. PubMed ID: 37034659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cheese consumption on atherosclerosis, atherosclerotic cardiovascular diseases and its complications: A two-sample Mendelian randomization study.
    Xie Y; Chen H; Xu J; Qu P; Zhu L; Tan Y; Zhang M; Liu L
    Nutr Metab Cardiovasc Dis; 2024 Mar; 34(3):691-698. PubMed ID: 38161113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study.
    Levin MG; Klarin D; Assimes TL; Freiberg MS; Ingelsson E; Lynch J; Natarajan P; O'Donnell C; Rader DJ; Tsao PS; Chang KM; Voight BF; Damrauer SM;
    JAMA Netw Open; 2021 Jan; 4(1):e2034461. PubMed ID: 33464320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells.
    Eid RE; Rao DA; Zhou J; Lo SF; Ranjbaran H; Gallo A; Sokol SI; Pfau S; Pober JS; Tellides G
    Circulation; 2009 Mar; 119(10):1424-32. PubMed ID: 19255340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular safety of genetically proxied interleukin-5 inhibition: A mendelian randomization study.
    Alton P; Hughes DM; Zhao SS
    Respir Investig; 2023 Mar; 61(2):149-152. PubMed ID: 36682083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging genetic data to investigate the effects of interleukin-6 receptor signalling on levels of 40 circulating cytokines.
    Rahman RP; McEwan L; Ryan DK; Gill D
    Br J Clin Pharmacol; 2022 Mar; 88(3):1373-1378. PubMed ID: 34506050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups.
    Georgakis MK; Malik R; Richardson TG; Howson JMM; Anderson CD; Burgess S; Hovingh GK; Dichgans M; Gill D
    BMC Med; 2022 Aug; 20(1):245. PubMed ID: 35948913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of interleukin 6 signaling might reduce the risk of periodontitis: a drug target Mendelian randomization study.
    Nolde M; Alayash Z; Reckelkamm SL; Kocher T; Ehmke B; Holtfreter B; Baurecht H; Georgakis MK; Baumeister SE
    Front Immunol; 2023; 14():1160148. PubMed ID: 37342352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
    Yuan S; Lin A; He QQ; Burgess S; Larsson SC
    Int J Cardiol; 2020 Aug; 313():99-104. PubMed ID: 32223966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R.
    Cupido AJ; Asselbergs FW; Natarajan P; ; Ridker PM; Hovingh GK; Schmidt AF
    Br J Clin Pharmacol; 2022 Jun; 88(6):2875-2884. PubMed ID: 34931349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is periodontitis a risk factor for ischaemic stroke, coronary artery disease and subclinical atherosclerosis? A Mendelian randomization study.
    Bell S; Gibson JT; Harshfield EL; Markus HS
    Atherosclerosis; 2020 Nov; 313():111-117. PubMed ID: 33038664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically Proxied Inhibition of Coagulation Factors and Risk of Cardiovascular Disease: A Mendelian Randomization Study.
    Yuan S; Burgess S; Laffan M; Mason AM; Dichgans M; Gill D; Larsson SC
    J Am Heart Assoc; 2021 Apr; 10(8):e019644. PubMed ID: 33834859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive Effects of Genetic Interleukin-6 Signaling Downregulation and Low-Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization Analysis.
    Georgakis MK; Malik R; Burgess S; Dichgans M
    J Am Heart Assoc; 2022 Jan; 11(1):e023277. PubMed ID: 34927447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
    Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
    Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
    Georgakis MK; Gill D; Rannikmäe K; Traylor M; Anderson CD; Lee JM; Kamatani Y; Hopewell JC; Worrall BB; Bernhagen J; Sudlow CLM; Malik R; Dichgans M
    Circulation; 2019 Jan; 139(2):256-268. PubMed ID: 30586705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of Hypercoagulability Driving Stroke Risk in Obesity: A Mendelian Randomization Study.
    Daghlas I; Gill D
    Neurology; 2024 Jul; 103(1):e209431. PubMed ID: 38861688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization.
    Henry A; Gordillo-Marañón M; Finan C; Schmidt AF; Ferreira JP; Karra R; Sundström J; Lind L; Ärnlöv J; Zannad F; Mälarstig A; Hingorani AD; Lumbers RT;
    Circulation; 2022 Apr; 145(16):1205-1217. PubMed ID: 35300523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
    Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
    BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis.
    Chen W; Wang S; Lv W; Pan Y
    BMJ Open Diabetes Res Care; 2020 May; 8(1):. PubMed ID: 32398352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.